InvestorsHub Logo
Replies to #36 on Biotron (BITRF)

misiu143

10/03/18 1:57 PM

#37 RE: Stockfun1 #36

It is a little stretch for now ...imo......

Monotherapy with BIT225 in the past show there was no improvement of Viral load ,
But did cause reduction in HIV in certain white blood cells , macrophages .

So even if all the results will be great patients will need HAART or
Loronlimab (Pro 140 ) from CYDY , together with BIT225.
But it is very interesting study , this is why I too bough some shares today.